Arrow Financial’s Idexx Laboratories IDXX Stock Holding History

Arrow Financial’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-285	Closed	-$78K	–	333
2019 Q2	$78K	Buy	+285	New	+$70.2K	0.02%	206

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Arrow Financial's IDXX Position: Q3 2019 in Review

Arrow Financial sold out of Idexx Laboratories (IDXX) in Q3 2019, closing a stake of 285 shares — an estimated $78K sold.

Arrow Financial first reported a position in IDXX in Q2 2019 and held it in 1 quarter. The position peaked at $78K in Q2 2019. 719 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

Arrow Financial reported no remaining Idexx Laboratories position as of Q3 2019 after selling out during the quarter.
Arrow Financial sold 285 Idexx Laboratories shares in Q3 2019, an estimated $78K.
Arrow Financial first reported a position in Idexx Laboratories in Q2 2019 and held it in 1 quarter.
Arrow Financial's Idexx Laboratories position peaked at $78K in Q2 2019.
719 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on Arrow Financial's 13F filing for Q3 2019, filed 28 Oct 2019.